Literature DB >> 17582222

The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.

Shirley K Knauer1, Carolin Bier, Peter Schlag, Johannes Fritzmann, Wolfgang Dietmaier, Franz Rödel, Ludger Klein-Hitpass, Adoriàn F Kovács, Claudia Döring, Martin-Leo Hansmann, Wolf-Karsten Hofmann, Martin Kunkel, Christoph Brochhausen, Knut Engels, Burkhard M Lippert, Wolf Mann, Roland H Stauber.   

Abstract

Survivin is described as a bifunctional protein inhibiting apoptosis and regulating mitosis. However, the biological functions and contributions to cancer progression of survivin splice variants are controversially discussed. We here show that the intracellular localization of these splice variants depends on a Crm1-dependent nuclear export signal (NES) present in survivin, surviving(-2B) and survivin(-3B), but absent in survivin(-deltaEx3) and survivin(-2alpha). Survivin isoforms lack an active nuclear import signal and are able to enter the nucleus by passive diffusion. Only survivin(-3B) but none of the other splice variants is cytoprotective and able to efficiently interact with chromosomal passenger complex (CPC) proteins. The NES together with efficient CPC formation is required for the cytoprotective activity of survivin isoforms, as well as for their correct localization and function during cell division. In the tumours from breast, colorectal, head and neck cancer, lymphoma and leukemia patients, survivin and survivin(-2B) were found overexpressed. However, survivin was the predominant form detected, and the other survivin isoforms were only expressed at low levels in tumours. Our data provide a molecular rationale for the localization and activity of survivin variants, and conclude that survivin isoforms are unlikely to modulate survivin in trans in cancer patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582222

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.

Authors:  Pablo E Vivas-Mejia; Cristian Rodriguez-Aguayo; Hee-Dong Han; Mian M K Shahzad; Fatma Valiyeva; Mineko Shibayama; Arturo Chavez-Reyes; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2011-04-21       Impact factor: 12.531

2.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 3.  Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Authors:  Rosalia de Necochea-Campion; Chien-Shing Chen; Saied Mirshahidi; Frank D Howard; Nathan R Wall
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

4.  The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival.

Authors:  Anna G Antonacopoulou; Konstantina Floratou; Vasiliki Bravou; Anastasia Kottorou; Fotinos-Ioannis Dimitrakopoulos; Stella Marousi; Michalis Stavropoulos; Angelos K Koutras; Chrisoula D Scopa; Haralabos P Kalofonos
Journal:  Cell Oncol (Dordr)       Date:  2011-05-03       Impact factor: 6.730

5.  Cell-based analysis of structure-function activity of threonine aspartase 1.

Authors:  Carolin Bier; Shirley K Knauer; Alexander Klapthor; Andrea Schweitzer; Alexander Rekik; Oliver H Krämer; Rolf Marschalek; Roland H Stauber
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

6.  Endogenous knockdown of survivin improves chemotherapeutic response in ALL models.

Authors:  D J Morrison; L E Hogan; G Condos; T Bhatla; N Germino; N P Moskowitz; L Lee; D Bhojwani; T M Horton; I Belitskaya-Levy; L M Greenberger; I D Horak; S A Grupp; D T Teachey; E A Raetz; W L Carroll
Journal:  Leukemia       Date:  2011-08-16       Impact factor: 11.528

Review 7.  Association of survivin splice variants with prognosis and treatment of breast cancer.

Authors:  Anastasia Pavlidou; Christos Kroupis; Kleanthi Dimas
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.

Authors:  Quan-Xing Ge; Yu-Yuan Li; Yu-Qiang Nie; Wen-Ge Zuo; Yan-Lei Du
Journal:  Med Oncol       Date:  2013-03-15       Impact factor: 3.064

9.  Functional analysis of a survivin-like gene in Bombyx mori.

Authors:  Hui Tang; Yu Wu; Haixiang Wu; Yan Wu; Huiling Wu; Wenbing Wang
Journal:  Cytotechnology       Date:  2013-03-26       Impact factor: 2.058

10.  Assessment of mRNA splice variants by qRT-PCR.

Authors:  Ileabett M Echevarria Vargas; Pablo E Vivas-Mejía
Journal:  Methods Mol Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.